Literature DB >> 7874834

Primary localized orbital amyloidosis composed of the immunoglobulin gamma heavy chain CH3 domain.

S Y Tan1, I E Murdoch, T J Sullivan, J E Wright, O Truong, J J Hsuan, P N Hawkins, M B Pepys.   

Abstract

1. Primary orbital amyloidosis is a rare form of localized amyloidosis in which the precursor protein has not previously been identified. We report here the first extraction of amyloid fibrils from a tissue biopsy containing orbital amyloid, and characterization of the fibril protein. 2. The N-terminal nine residues were identical with residues 278-286 and 275-283 of the third constant (CH3) domains of IgG1 and IgG4 gamma heavy chains, respectively. The mass of the fibril subunit protein was 6125Da by time-of-flight mass spectrometry, compared with the expected masses of 6169.9Da and 6214.9Da for the CH3 domains of gamma 1 from residue 278 and gamma 4 from residue 275, respectively. The fibril protein thus appeared to consist exclusively of an immunoglobulin heavy chain constant domain. 3. Only two examples of immunoglobulin heavy chain derived amyloid have been reported previously and both of these, as well as all published cases of the usual immunoglobulin light chain derived amyloid, contained variable domain sequence. The present case therefore represents a form of local, presumably clonal, B-cell/plasma-cell disorder characterized uniquely by deposition of an amyloidogenic immunoglobulin heavy chain constant domain fragment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874834     DOI: 10.1042/cs0870487

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  6 in total

1.  Primary localised amyloidosis of the orbit.

Authors:  I E Murdoch; T J Sullivan; I Moseley; P N Hawkins; M B Pepys; S Y Tan; A Garner; J E Wright
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

2.  Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.

Authors:  D R Booth; S Y Tan; S E Booth; G A Tennent; W L Hutchinson; J J Hsuan; N F Totty; O Truong; A K Soutar; P N Hawkins; M Bruguera; J Caballería; M Solé; J M Campistol; M B Pepys
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

Review 3.  Monoclonal origin of localised orbital amyloidosis detected by molecular analysis.

Authors:  S Pasternak; V A White; R D Gascoyne; S R Perry; R L Johnson; J Rootman
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

4.  Primary local orbital amyloidosis: biochemical identification of the immunoglobulin light chain kappaIII subtype in a small formalin fixed, paraffin wax embedded tissue sample.

Authors:  B Kaplan; B M Martin; H I Cohen; J Manaster; Y Kassif; U Rehany; A Livneh
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

5.  Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis.

Authors:  Batia Kaplan; Brian M Martin; Olga Boykov; Rivka Gal; Mordechai Pras; Itzhak Shechtman; Milton Saute; Mordechai R Kramer
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

6.  Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum.

Authors:  Vincent Audard; Benoit Georges; Philippe Vanhille; Cécile Toly; Benjamin Deroure; Fadi Fakhouri; René Cuvelier; Xavier Belenfant; Brigitte Surin; Pierre Aucouturier; Béatrice Mougenot; Pierre Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 8.237

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.